Mini Sample Mouse OPG (Osteoprotegerin) ELISA Kit
中文名称:微量法小鼠骨保护素(OPG)酶联免疫吸附测定试剂盒

Price:
- 反应性: Mouse
- 检测范围: 125-8000 pg/mL
- 灵敏度: 62.87 pg/mL
系列介绍 | MS为Mini Sample的缩写。MS系列试剂盒的上样量仅为传统夹心法ELISA试剂盒的1/4,能有效解决实验样本体积不够的问题。Elabscience®自主开发的新技术,旨在帮助您以更高效的方式进行科学研究。 |
用途 | 试剂盒用于体外定量检测小鼠血清、血浆或其他生物体液中OPG浓度 |
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠OPG抗体包被于酶标板上,实验时样品(或标准品)中的小鼠OPG会与包被抗体结合。后依次加入生物素化的抗小鼠OPG抗体和辣根过氧化物酶标记的亲和素,抗小鼠OPG抗体与结合在包被抗体上的小鼠OPG结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,OPG浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中OPG的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Mouse |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 125-8000 pg/mL |
灵敏度 | 62.87 pg/mL |
样本体积 | 25 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的小鼠OPG,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
-
Development of an optogenetics tool, Opto-RANK, for control of osteoclast differentiation using blue light
IF: 4.600 -
Amyloid-β peptide treatment reverses bone loss in the mandibular condyle via Wnt signalling pathway
IF: 2.100 -
Enhanced ectopic bone formation by strontium-substituted calcium phosphate ceramics through regulation of osteoclastogenesis and osteoblastogenesis
IF: 7.590 -
Modified Qing’ e Pills exerts anti-osteoporosis effects and prevents bone loss by enhancing type H blood vessel formation
IF: 6.055Journal: Frontiers in Endocrinology (2022)Reactivity:MouseSample Type:femur -
CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners
IF: 11.799 -
Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study
IF: 4.360 -
Anti-osteoporosis effect of Semen Cuscutae in ovariectomized mice through inhibition of bone resorption by osteoclasts
IF: 4.360Journal: JOURNAL OF ETHNOPHARMACOLOGY (2021)Reactivity:MouseSample Type:serum -
CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis
IF: 8.986 -
Amyloid β peptide promotes bone formation by regulating Wnt/β-catenin signaling and the OPG/RANKL/RANK system
IF: 4.966 -
CR6-interacting factor-1 contributes to osteoclastogenesis by inducing receptor activator of nuclear factor κB ligand after radiation
IF: 3.231